| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations of profibrinolytic receptor annexin A2 in pre-eclampsia: A possible role in placental thrombin formation
|
Xin, Hong
|
|
2012
|
129 |
Supplement 2 |
p. 563-567
5 p.
|
artikel
|
| 2 |
Association of blood transfusion and venous thromboembolism after colorectal cancer resection
|
Xenos, Eleftherios S.
|
|
2012
|
129 |
Supplement 2 |
p. 568-572
5 p.
|
artikel
|
| 3 |
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
|
Gary, T.
|
|
2012
|
129 |
Supplement 2 |
p. S181-
1 p.
|
artikel
|
| 4 |
BMP-2 inhibits TF expression in human monocytes by shutting down MAPK signaling and AP-1 transcriptional activity
|
Egorina, E.M.
|
|
2012
|
129 |
Supplement 2 |
p. e106-e111
nvt p.
|
artikel
|
| 5 |
Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: Implications for coagulation regulation on tumor cells
|
Sierko, Ewa
|
|
2012
|
129 |
Supplement 2 |
p. e112-e118
nvt p.
|
artikel
|
| 6 |
Determination of alpha-2-macroglobulin complexes by a new immuno-activity assay
|
Atkinson, Helen M.
|
|
2012
|
129 |
Supplement 2 |
p. 635-640
6 p.
|
artikel
|
| 7 |
Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
|
Wolzt, Michael
|
|
2012
|
129 |
Supplement 2 |
p. e83-e91
nvt p.
|
artikel
|
| 8 |
Endothelial cell activation markers in cancer
|
Blann, Andrew D.
|
|
2012
|
129 |
Supplement 2 |
p. S122-S126
5 p.
|
artikel
|
| 9 |
Esophageal variceal bleeding as a potential marker of liver cancer in patients with liver cirrhosis
|
Montomoli, J.
|
|
2012
|
129 |
Supplement 2 |
p. S166-
1 p.
|
artikel
|
| 10 |
Evaluation of assay performance monitoring Rivaroxaban with TECHNOCHROM anti-Xa on different analyzers
|
Leitner, M.
|
|
2012
|
129 |
Supplement 2 |
p. S187-
1 p.
|
artikel
|
| 11 |
Evidence that protease-activated receptor-2 (PAR-2) supports angiogenesis in a murine melanoma model
|
Oliveira, A.
|
|
2012
|
129 |
Supplement 2 |
p. S192-
1 p.
|
artikel
|
| 12 |
Factor XIII, clot structure, thrombosis
|
Bagoly, Zsuzsa
|
|
2012
|
129 |
Supplement 2 |
p. 382-387
6 p.
|
artikel
|
| 13 |
Fibrinogen-like protein 2 (FGL-2) – a novel biomarker for cancer
|
Rabizadeh, E.
|
|
2012
|
129 |
Supplement 2 |
p. S192-
1 p.
|
artikel
|
| 14 |
Health care expenditures associated with venous thromboembolism among children
|
Boulet, Sheree L.
|
|
2012
|
129 |
Supplement 2 |
p. 583-587
5 p.
|
artikel
|
| 15 |
Hemostatic factors, innate immunity and malignancy
|
Degen, Jay L.
|
|
2012
|
129 |
Supplement 2 |
p. S1-S5
5 p.
|
artikel
|
| 16 |
Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-β/Smad signaling pathway
|
Mu, En
|
|
2012
|
129 |
Supplement 2 |
p. 479-485
7 p.
|
artikel
|
| 17 |
Hypoxia induces Smad2 phosphorylation signaling and increases stem cell-like properties and multi-drug resistance in K562 leukemic cells
|
Cui, X.-Y.
|
|
2012
|
129 |
Supplement 2 |
p. S191-S192
2 p.
|
artikel
|
| 18 |
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study
|
Beijers, Hanneke J.B.H.
|
|
2012
|
129 |
Supplement 2 |
p. 557-562
6 p.
|
artikel
|
| 19 |
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease
|
Linnemann, Birgit
|
|
2012
|
129 |
Supplement 2 |
p. 720-724
5 p.
|
artikel
|
| 20 |
Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests
|
Gremmel, Thomas
|
|
2012
|
129 |
Supplement 2 |
p. 616-622
7 p.
|
artikel
|
| 21 |
Inhibition of FGF-2 angiogenic activity by novel small molecules mimetic of thrombospondin-1 (TSP-1)
|
Foglieni, C.
|
|
2012
|
129 |
Supplement 2 |
p. S193-
1 p.
|
artikel
|
| 22 |
Measurement of the new anticoagulants
|
Harenberg, Job
|
|
2012
|
129 |
Supplement 2 |
p. S106-S113
8 p.
|
artikel
|
| 23 |
PAR-2 activation induces migration but not proliferation of pancreatic cancer cells
|
Shi, K.
|
|
2012
|
129 |
Supplement 2 |
p. S191-
1 p.
|
artikel
|
| 24 |
Performance of the Pulmonary Embolism Rule-out Criteria (the PERC rule) combined with low clinical probability in high prevalence population
|
Penaloza, Andrea
|
|
2012
|
129 |
Supplement 2 |
p. e189-e193
nvt p.
|
artikel
|
| 25 |
Peripheral blood microparticle-associated tissue factor activity in stage III and IV lung cancer
|
Martino, F.
|
|
2012
|
129 |
Supplement 2 |
p. S171-
1 p.
|
artikel
|
| 26 |
Platelet CLEC-2 and podoplanin in cancer metastasis
|
Lowe, Kate L.
|
|
2012
|
129 |
Supplement 2 |
p. S30-S37
8 p.
|
artikel
|
| 27 |
Platelet-leukocyte interactions in thrombosis
|
Cerletti, Chiara
|
|
2012
|
129 |
Supplement 2 |
p. 263-266
4 p.
|
artikel
|
| 28 |
Platelet systems biology using integrated genetic and proteomic platforms
|
Bahou, Wadie F.
|
|
2012
|
129 |
Supplement 2 |
p. S38-S45
8 p.
|
artikel
|
| 29 |
Podoplanin expression in advanced atherosclerotic lesions of human aortas
|
Hatakeyama, Kinta
|
|
2012
|
129 |
Supplement 2 |
p. e70-e76
nvt p.
|
artikel
|
| 30 |
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients
|
Ay, Cihan
|
|
2012
|
129 |
Supplement 2 |
p. S6-S9
4 p.
|
artikel
|
| 31 |
Prevalence of pulmonary embolism in colorectal cancer at time of diagnosis
|
Poulsen, M.
|
|
2012
|
129 |
Supplement 2 |
p. S165-
1 p.
|
artikel
|
| 32 |
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1
|
Siragusa, Sergio
|
|
2012
|
129 |
Supplement 2 |
p. e171-e176
nvt p.
|
artikel
|
| 33 |
Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines
|
Dutra-Oliveira, A.
|
|
2012
|
129 |
Supplement 2 |
p. S190-S191
2 p.
|
artikel
|
| 34 |
Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue
|
Sierko, Ewa
|
|
2012
|
129 |
Supplement 2 |
p. e92-e96
nvt p.
|
artikel
|
| 35 |
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion
|
Poli, Daniela
|
|
2012
|
129 |
Supplement 2 |
p. 588-590
3 p.
|
artikel
|
| 36 |
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests
|
Asmis, L.M.
|
|
2012
|
129 |
Supplement 2 |
p. 492-498
7 p.
|
artikel
|
| 37 |
Role of the FGF-2-binding fragment of thrombospondin-1 (TSP-1) in tumor progression
|
Resovi, A.
|
|
2012
|
129 |
Supplement 2 |
p. S193-
1 p.
|
artikel
|
| 38 |
Safety and efficacy of an educational program in reducing thrombotic and infective complications of peripherally inserted central catheters (PICCs) in haematological patients
|
Malato, A.
|
|
2012
|
129 |
Supplement 2 |
p. S176-S177
2 p.
|
artikel
|
| 39 |
Sepsis, thrombosis and organ dysfunction
|
Semeraro, Nicola
|
|
2012
|
129 |
Supplement 2 |
p. 290-295
6 p.
|
artikel
|
| 40 |
Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways
|
Shah, Vidhi P.
|
|
2012
|
129 |
Supplement 2 |
p. 36-42
7 p.
|
artikel
|
| 41 |
The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives
|
Schlesinger, Martin
|
|
2012
|
129 |
Supplement 2 |
p. 603-610
8 p.
|
artikel
|
| 42 |
The pathogenesis of warfarin-associated venous limb ischemia and gangrene complicating cancer: clinical and laboratory parallels with heparin-induced thrombocytopenia (HIT)
|
Warkentin, T.E.
|
|
2012
|
129 |
Supplement 2 |
p. S159-S160
2 p.
|
artikel
|
| 43 |
The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2
|
Machovec, Kelly A.
|
|
2012
|
129 |
Supplement 2 |
p. 793-796
4 p.
|
artikel
|
| 44 |
Thrombin generation in severe sepsis
|
Petros, S.
|
|
2012
|
129 |
Supplement 2 |
p. 797-800
4 p.
|
artikel
|
| 45 |
Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation
|
Koncz, Zsuzsa
|
|
2012
|
129 |
Supplement 2 |
p. 508-513
6 p.
|
artikel
|
| 46 |
Thrombosis and Acute coronary syndrome
|
Abbate, Rosanna
|
|
2012
|
129 |
Supplement 2 |
p. 235-240
6 p.
|
artikel
|
| 47 |
Thrombosis and obesity: Cellular bases
|
Lorenzet, Roberto
|
|
2012
|
129 |
Supplement 2 |
p. 285-289
5 p.
|
artikel
|
| 48 |
Time dependence of clopidogrel loading effect: Platelet activation versus platelet aggregation
|
Gurbel, Paul A.
|
|
2012
|
129 |
Supplement 2 |
p. 1-2
2 p.
|
artikel
|
| 49 |
Tissue factor isoforms in cancer and coagulation: May the best isoform win
|
Kocatürk, Begüm
|
|
2012
|
129 |
Supplement 2 |
p. S69-S75
7 p.
|
artikel
|
| 50 |
Unfractionated heparin promotes LPS-induced endothelial barrier dysfunction: A preliminary study on the roles of angiopoietin/Tie2 axis
|
Li, Xu
|
|
2012
|
129 |
Supplement 2 |
p. e223-e228
nvt p.
|
artikel
|
| 51 |
Variability of INR in a sample of cancer patients in the WARP trial
|
Young, A.
|
|
2012
|
129 |
Supplement 2 |
p. S186-
1 p.
|
artikel
|
Tijdschrift beschrijving